Variable
|
Total no.
|
No. with anaemia 1 week post-initiation of ACTs
|
OR (95% CI)
|
P value
|
AOR (95% CI)
|
P value
|
---|
Gender
|
Female
|
278
|
132
|
1
| | | |
Male
|
325
|
168
|
0.8 (0.6–1.2)
|
0.34
|
–
|
–
|
Age (month)
|
> 15
|
541
|
255
|
1
| |
1
| |
≤ 15
|
58
|
42
|
2.9 (1.6–5.4)
|
< 0.0001
|
2.5 (1.4–4.7)
|
0.003
|
Duration of illness (day)
|
≤ 2
|
203
|
101
|
1
| | | |
> 2
|
192
|
100
|
1.0 (0.7–1.6)
|
1.0
|
–
|
–
|
Enrolment body temperature (°C)
|
≤ 37.4
|
214
|
104
|
1
| | | |
> 37.4
|
390
|
197
|
1.1 (1.0–1.9)
|
0.71
|
–
|
–
|
History of fever at enrolment
|
Absent
|
99
|
39
|
1
| |
1
| |
Present
|
505
|
262
|
1.7 (1.1–2.6)
|
0.03
|
1.8 (1.1–2.9)
|
0.01
|
Fever on day 1
|
Absent
|
501
|
255
|
1
| | | |
Present
|
70
|
38
|
1.1 (0.7–1.9)
|
0.69
|
–
|
–
|
Haematocrit (%)
|
> 35
|
140
|
42
|
1
| |
1
| |
≤ 35
|
464
|
259
|
2.9 (2.0–4.4)
|
< 0.0001
|
2.9 (1.9–4.4)
|
<0.0001
|
Parasitaemia (μL−1)
|
≤ 50,000
|
434
|
213
|
1
| | | |
> 50,000
|
166
|
87
|
1.1 (0.8–1.6)
|
0.52
|
–
|
–
|
Parasitaemia on day 1
|
Absent
|
244
|
111
|
1
| | | |
Present
|
360
|
190
|
1.3 (1.0–1.9)
|
0.09
|
–
|
–
|
Parasitaemia day 1 or 2
|
Absent
|
233
|
104
|
1
| |
1
| |
Present
|
371
|
197
|
1.4 (1.0–2.0)
|
0.04
|
1.3 (0.9–1.9)
|
0.11
|
Gametocytaemia
|
Absent
|
579
|
289
|
1
| | | |
Present
|
25
|
12
|
0.9 (0.4–2.1)
|
1.0
|
–
|
–
|
Parasite clearance time (day)
|
≤ 2
|
468
|
234
|
1
| | | |
> 2
|
136
|
67
|
1.0 (0.7–1.4)
|
0.96
|
–
|
–
|
Fever clearance time (day)
|
≤ 2
|
367
|
186
|
1
| | | |
> 2
|
13
|
9
|
1.9 (0.9–4.3)
|
0.13
|
–
|
–
|
Season of enrolment
|
Dry (November–March)
|
45
|
17
|
1
| | | |
Wet (April–October)
|
559
|
284
|
1.7 (0.9–3.2)
|
0.13
|
–
|
–
|
Drug treatment
|
DHP
|
226
|
110
|
1
| | | |
AL
|
191
|
101
|
1.2 (0.8–1.7)
|
0.49
|
–
|
–
|
AA
|
187
|
90
|
1.0 (0.7–1.4)
|
1.0
| | |
-
OR odd ratio, AOR adjusted odd ratio, CI confidence interval, DHP dihydroartemisinin-piperaquine, AL artemether-lumefantrine, AA artesunate-amodiaquine, ACTs artemisinin-based combination treatments